Hong Kong Office REITs Stock News

China Resources Medical Holdings (SEHK:1515) has reported its FY 2025 first half numbers with revenue of C¥4.5b and basic EPS of C¥0.27, alongside net income of C¥339.5m, setting a clear reference point against prior periods. Over recent halves, the company has seen revenue move from C¥4.98b in 1H 2024 to C¥4.88b in 2H 2024 and C¥4.52b in 1H 2025, with basic EPS shifting from C¥0.34 in 1H 2024 to C¥0.10 in 2H 2024 and C¥0.27 in 1H 2025. For investors, the key question now is how these...

Beijing Enterprises Environment Group (SEHK:154) just posted its FY 2025 first half numbers, reporting revenue of C¥722.4 million and basic EPS of C¥0.085, with net income excluding extra items at C¥127.1 million. Trailing 12 month revenue was C¥1.4 billion and basic EPS was C¥0.155. The company reported revenue of C¥803.2 million and basic EPS of C¥0.094 in 1H FY 2024, followed by revenue of C¥860.9 million and EPS of C¥0.100 in 2H FY 2024. Trailing 12 month net income excluding extra items...

Jiaxin International Resources Investment (SEHK:3858) has put out its FY 2025 numbers with first half revenue of HK$126.3 million and a basic EPS loss of HK$0.018, against a trailing twelve month picture that includes HK$1.1 billion in revenue and EPS of HK$0.82. Over recent periods the company has moved from zero revenue in both halves of FY 2024, when EPS losses were HK$0.193 and HK$0.332, to the current revenue base and a positive trailing EPS figure, giving you a very different backdrop...

China Conch Venture Holdings (SEHK:586) has put up a clean set of numbers for FY 2025 so far, with first half revenue of C¥3.1b and basic EPS of C¥0.76, alongside trailing twelve month revenue of C¥6.5b and EPS of C¥1.32. The company has seen revenue hold around the C¥3.1b mark across recent half year periods, while basic EPS has moved between C¥0.49 and C¥0.76 per half. This has fed into trailing twelve month net income of C¥2.2b and a higher net margin over the last year, which frames this...

GenFleet Therapeutics (Shanghai) (SEHK:2595) has just released its FY 2025 figures, with first half revenue at C¥88.7 million and basic EPS at a loss of C¥27.02 per share, setting the tone for a period where margins remain firmly in loss-making territory. The company has seen first half revenue move from C¥0 in 2024 to C¥88.7 million in 2025, while basic EPS shifted from a loss of C¥18.02 to a deeper loss of C¥27.02. This puts the spotlight on how quickly revenue can scale against persistent...

Investors may be wondering whether PetroChina's recent performance still leaves room for value, or if the easier gains are already behind it. The stock last closed at HK$10.88, with returns of 1.4% over 7 days, 13.8% over 30 days, 27.7% year to date and 85.3% over 1 year. This performance may have shifted how investors view its potential and risk. Recent coverage has focused on PetroChina's share price strength and its role in the wider energy sector. This gives investors more reasons to...

DPC Dash (SEHK:1405) has put fresh numbers on the table for FY 2025, with first half revenue of C¥2.6b and basic EPS of C¥0.50, alongside trailing twelve month revenue of C¥5.4b and EPS of C¥1.08 that highlight how the top line and per share earnings are tracking. Over the past few reporting periods, revenue has moved from C¥2.0b in 1H 2024 to C¥2.3b in 2H 2024 and then to C¥2.6b in 1H 2025, while EPS has gone from C¥0.08 to C¥0.34 and then to C¥0.50. This sets up a story where investors will...

Keck Seng Investments (Hong Kong) (SEHK:184) has opened FY 2025 with first half revenue of HK$772.6 million and basic EPS of HK$0.03, setting a more muted tone against a backdrop of previously higher earnings. Over recent periods, the company has reported revenue of HK$809.0 million and EPS of HK$0.26 in 1H 2024, followed by revenue of HK$883.0 million and EPS of HK$0.50 in 2H 2024, before arriving at the current 1H 2025 levels. With a 15.9% net profit margin over the last 12 months and a...

Linmon Media (SEHK:9857) has just posted its FY 2025 first half numbers, with revenue of C¥401.3 million and basic EPS of C¥0.03, while trailing twelve month revenue stands at C¥862.5 million and EPS at C¥0.09. Over recent reporting periods, revenue has moved from C¥192.5 million in 1H FY 2024 to C¥464.5 million in 2H FY 2024 and then to C¥401.3 million in 1H FY 2025. This has come alongside a swing from a net loss of C¥52.6 million in 1H FY 2024 and C¥136.6 million in 2H FY 2024 to net...

Beijing Enterprises Water Group (SEHK:371) has just posted its FY 2025 first half numbers, with revenue of C¥10.5b and basic EPS of C¥0.084, alongside trailing 12 month revenue of C¥22.1b and basic EPS of C¥0.146 that sit against a recent 7.6% earnings growth rate and a 7.6% net margin in the dataset. Over the past reported periods, revenue has moved from C¥24.3b to C¥23.4b on a trailing basis while basic EPS shifted from C¥0.156 to C¥0.146. This gives a clearer view of how the top line and...

Financial Street Securities (SEHK:1476) has put up a solid set of FY 2025 numbers, with first half revenue of C¥1.5b and basic EPS of C¥0.09 setting the tone after a year in which trailing twelve month EPS reached C¥0.12 on revenue of about C¥3.2b. Over the past few reporting periods, revenue has moved from C¥962.4m in 1H 2024 to C¥1.4b in 2H 2024 and then to C¥1.5b in 1H 2025, while basic EPS has stepped from C¥0.02 to C¥0.05 and now C¥0.09. This points to meaningfully stronger earnings...

Shuangdeng Group (SEHK:6960) has reported its FY 2025 first half results with revenue of C¥2.2b and basic EPS of C¥0.45, setting the tone for a period where profitability and scale are both in focus. Over the past three first half periods, revenue has moved from C¥2.27b in 2023 to C¥1.78b in 2024 and C¥2.25b in 2025, while basic EPS over the same stretch shifted from C¥0.65 to C¥0.46 and then C¥0.45. This provides a clear view of how the top line and per share earnings have tracked together...

Guotai Junan International Holdings (SEHK:1788) has reported its FY 2025 first half results with revenue of HK$1,638.1 million and basic EPS of HK$0.058, set against a trailing twelve month backdrop of HK$3.8 billion in revenue and EPS of HK$0.141, where earnings over the last year rose 286.8%. Over recent periods the company has seen revenue move from HK$1,067.8 million and EPS of HK$0.020 in 1H 2024 to HK$1,076.0 million and EPS of HK$0.016 in 2H 2024, before reaching the latest HK$1,638.1...

IGG (SEHK:799) has put fresh numbers on the table for FY 2025, with first half revenue of HK$2.7b and basic EPS of HK$0.28. Trailing twelve month EPS sits at HK$0.51 on revenue of HK$5.5b and net income of HK$580.5m, giving investors a clear read on recent profitability. The company has seen half year revenue move between HK$2.7b in 1H 2024, HK$3.0b in 2H 2024, and HK$2.7b in 1H 2025, with basic EPS ranging from HK$0.29 to HK$0.22 and HK$0.28 across those periods. This helps set the scene for...

Robosense Technology (SEHK:2498) closed FY 2025 with fourth quarter revenue of C¥750.7 million and basic EPS of C¥0.24, while the trailing twelve months showed revenue of C¥1.9 billion and a basic EPS loss of C¥0.32. Over recent quarters, revenue has moved from C¥513.9 million in Q4 FY 2024 to C¥750.7 million in Q4 FY 2025, with quarterly EPS shifting from a loss of C¥0.30 to a profit of C¥0.24. For investors, the mix of higher quarterly revenue, a swing to quarterly profitability, and an...

Genertec Universal Medical Group (SEHK:2666) has reported FY 2025 first half revenue of CNY 7.5b and basic EPS of CNY 0.65. Trailing twelve month EPS stands at CNY 1.13 and revenue at CNY 14.9b, helping frame the current earnings picture. The company’s revenue has moved from CNY 6.4b in 2024 H1 to CNY 6.9b in 2024 H2 and then to CNY 7.5b in 2025 H1. Net income excluding extra items tracked from CNY 1,137.2m to CNY 894.5m and then CNY 1,228.1m, setting up a results season where investors are...

China Resources Pharmaceutical Group (SEHK:3320) FY 2025 Earnings Snapshot China Resources Pharmaceutical Group (SEHK:3320) has posted its latest FY 2025 numbers with first half revenue of about C¥131.9b and basic EPS of C¥0.33, set against trailing twelve month EPS of C¥0.64. The company has seen revenue move from roughly C¥128.6b in 1H 2024 to C¥131.9b in 1H 2025, while basic EPS shifted from C¥0.41 in 1H 2024 and C¥0.12 in 2H 2024 to C¥0.33 in the latest half. This sets up a discussion...

Dongyue Group (SEHK:189) has posted fresh FY 2025 numbers, with first half revenue of C¥7.5b, basic EPS of C¥0.47 and trailing 12 month EPS of C¥0.98 helping frame a sharp earnings rebound over the past year. The company has seen revenue move from C¥7.3b in the first half of FY 2024 to C¥7.5b in the first half of FY 2025, while net income excluding extra items shifted from C¥307.6m to C¥779.2m. This sets up investors to focus on how far the recent 102.5% trailing earnings growth and 11.4% net...

Intro InnoCare Pharma (SEHK:9969) just closed FY 2025 with fourth quarter revenue of C¥1.3b and net income of C¥706.9m, a sharp step up from the smaller quarterly figures that characterised most of the year. The company has seen quarterly revenue move from C¥311.7m in Q4 2024 to C¥381.3m in Q1 2025, C¥350.2m in Q2, C¥383.9m in Q3 and finally C¥1.3b in Q4, while basic EPS across the year swung between a gain of C¥0.01 in Q1 and losses of C¥0.0396 and C¥0.0188 in Q2 and Q3. This sets up a...

Bank of Chongqing (SEHK:1963) has wrapped up FY 2025 with fourth quarter revenue of C¥2,287.3 million and basic EPS of C¥0.18, while trailing twelve month revenue came in at C¥10,887.8 million with EPS of C¥1.53. Over the past year, revenue has moved from C¥10,074.5 million to C¥10,887.8 million on a trailing basis, alongside an 18% rise in earnings and a net profit margin that lifted from 47.6% to 51.9%. This points to a business that is converting more of its top line into profit. For...

Kingsoft (SEHK:3888) has wrapped up FY 2025 with fourth quarter revenue of CN¥2,618.3 million and basic EPS of CN¥0.72, capping off a year where trailing twelve month revenue stood at CN¥9.7 billion and EPS reached CN¥1.46. Over recent periods, revenue has moved from CN¥2,792.5 million in Q4 2024 to CN¥2,618.3 million in Q4 2025, while quarterly EPS shifted from CN¥0.35 to CN¥0.72. This came alongside net profit margin improving to 20.7% from 15% year over year. With trailing net income of...

Dividend proposal and earnings recap Crystal International Group (SEHK:2232) has proposed a final ordinary dividend of HK$0.245 per share for 2025, alongside full year results that show higher sales, net income and basic earnings per share compared with 2024. See our latest analysis for Crystal International Group. The latest dividend proposal and full year results land at a time when the share price is HK$6.17, with a 30 day share price return showing a 20.18% decline but a 1 year total...

AK Medical Holdings (SEHK:1789) has reported FY 2025 first half revenue of C¥694.2 million and basic EPS of C¥0.144. The trailing twelve month figures show C¥1.48 billion of revenue and C¥0.304 in EPS, alongside a 23.8% earnings growth rate and revenue growth of about 14.9% over the past year. Over recent reporting periods, the company has seen revenue move from C¥657.1 million in 1H 2024 to C¥689.3 million in 2H 2024 and C¥694.2 million in 1H 2025. Basic EPS shifted from C¥0.125 to C¥0.121...

IRC (SEHK:1029) has just released its FY 2025 first half numbers, reporting revenue of US$122.8 million and a basic EPS loss of US$0.08 per share, with net income excluding extra items showing a loss of US$102.0 million. The company has seen revenue move from US$112.3 million in the first half of FY 2024 to US$122.8 million in the first half of FY 2025, while EPS moved from a loss of US$0.02 to a deeper loss of US$0.08 over the same period. This sets up a results season in which margins and...